(Q73219990)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

title

Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Meltzer HY

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1321-1327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10578448%20AND%20SRC:MED&resulttype=core&format=json

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Patient response and resource management: another view of clozapine treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

What are the functional consequences of neurocognitive deficits in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Treatment-resistant schizophrenia--the role of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Clozapine: is another view valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

The role of serotonin in antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Is it possible to be schizophrenic yet neuropsychologically normal?

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Cognitive improvement in schizophrenia with novel antipsychotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Distinguishing change in primary and secondary negative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900255-3